Pineapple Inc. acquires Pineapple Wellness Inc. for 1M shares; adds hemp CBD e-commerce and retail store

PINEAPPLE, INC.

Acquired 100% of Pineapple Wellness from CFO/director Matthew Feinstein in exchange for 1M shares of common stock.
Acquired e-commerce platform PineappleWellness.com and a flagship retail location near Beverly Hills.
Expands nationwide hemp-derived CBD sales, complementing existing cannabis real estate leasing operations.
Shares issued under Section 4(a)(2) exemption from registration.
CEO expects Hemp-CBD market growth and plans pop-up events and educational seminars.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

PINEAPPLE, INC. amended Amendment to the Letter of Intent (the “Amended LOI”) with Matthew Feinstein (effective 2023-06-12).

Action: amendment
Agreement: equity purchase
Counterparty: Matthew Feinstein
Effective: 2023-06-12

Exact text from the filing

On June 12, 2023, Pineapple, Inc., a Nevada corporation (the “Company”) entered into an Amendment to the Letter of Intent, by and between the Company and Matthew Feinstein (the “Amended LOI”), which amends the Letter of Intent, dated September 28, 2022. Pursuant to the Amended LOI, the Company shall acquire 100% of the issued and outstanding shares of the common stock of Pineapple Wellness, Inc., a California corporation (“PW”) from Matthew Feinstein, the Chief Financial Officer, Director and shareholder of the Company and also the sole shareholder of PW, in exchange for 1,000,000 shares of the Company’s common stock, par value per share $0.0000001 (the “Shares”).

View on SEC.gov

Browse all material agreements →

PINEAPPLE, INC. filing history →

Source: SEC EDGAR

accession 0001493152-23-021155

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.